Interesting development with the advertising and distribution of drugs/peptides imported into Australia. The Therapeutic Goods Administration (TGA) has issued a claim in the Federal Court against PeptideClinics P/L claiming that they are falsely advertising the benefits of using these medications. In other words they are making false claims of efficacy. Peptide Clinics operate a website that allows access to the information, only if potential customers complete a questionnaire, that they claim is sufficient for a “doctor on staff” who on assessment of the responses to the questionnaire, is able to diagnose the medical condition and then prepare a scrip that will allow legal access to the substances. Sounds very dodgy doesn’t it.
The court documents contains this statement:-
The Website also contains information published by the Respondent that asserts a
number of purported benefits of Peptides and Peptide Treatments sold by the
Respondent including anti−ageing, body building, body fat and weight loss, injury
repair, tanning, heart health, mood regulation (including reducing anxiety and
depression), libido/sexual function enhancement, preventing sleeplessness, bone
health and optimising health and fitness goals.
And yes, TB4 is specifically mentioned.
A win for the TGA could be at odds with WADA and ASADA as claims of efficacy (performance enhancement) could be scuttled by the TGA.
I am right on this.